Trial intelligence / Profile preview

Omeprazole high vs low dose in acute peptic ulcer bleeding

NCT02724150Phase 4Withdrawn

Sponsor
Damascus Hospital
Start
Dec 2017
Primary completion
Feb 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of omeprazole in Peptic ulcer hemorrhage (PUB), sponsored by Damascus Hospital. Planned start Dec 2017; status: withdrawn.

02

Drugs

omeprazole
03

Conditions

Peptic ulcer hemorrhage (PUB)

Beyond the preview

Go deeper on NCT02724150.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02724150.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call